Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immunovant (IMVT)
NASDAQ:IMVT
Holding IMVT?
Track your performance easily
Immunovant (IMVT) Ownership Overview
2.73% Insiders
16.21% Mutual Funds
24.73% Other Institutional Investors
8.25% ETFs
48.08% Public Companies and Individual Investors
The ownership structure of Immunovant (IMVT) stock is a mix of institutional, retail, and individual investors. Approximately 49.19% of the company’s stock is owned by Institutional Investors, 2.73% is owned by Insiders, and 48.08% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 22, 2024 | Mark Levine Clo | xxxxxxxxxxxxx | $92893 |
| Nov 22, 2024 | xxxxxxxxxxxxx | $85334 | |
| Nov 22, 2024 | xxxxxxxxxxxxx | $106228 | |
| Nov 22, 2024 | Peter Salzmann Ceo,director | xxxxxxxxxxxxx | $424811 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $249120 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $34936439 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $40340994 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $67818504 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,390,981 | Institution | 4.35% | 165,270,769 | |
| 5,864,934 | Institution | 4.00% | 151,667,193 | |
| 5,218,427 | Institution | 3.56% | 134,948,522 | |
| 2,956,031 | Institution | 2.01% | 76,442,962 | |
| 2,378,762 | Institution | 1.62% | 61,514,785 | |
| 2,320,902 | Institution | 1.58% | 60,018,526 | |
| 1,703,267 | Institution | 1.16% | 44,046,485 | |
| 1,414,977 | Institution | 0.96% | 36,591,305 | |
| 1,285,554 | Institution | 0.88% | 33,244,426 | |
| 1,225,410 | Institution | 0.83% | 31,689,103 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,864,934 | Institution | 4.00% | 151,667,193 | |
| 5,218,427 | Institution | 3.56% | 134,948,522 | |
| 1,285,554 | Institution | 0.88% | 33,244,426 | |
| 1,172,024 | Institution | 0.80% | 30,308,541 | |
| 780,367 | Institution | 0.53% | 20,180,291 | |
| 747,112 | Institution | 0.51% | 19,320,316 | |
| 665,621 | Institution | 0.45% | 17,212,959 | |
| 653,221 | Institution | 0.45% | 16,892,295 | |
| 649,720 | Institution | 0.44% | 16,801,759 | |
| 642,615 | Institution | 0.44% | 16,618,024 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,100,541 | Institution | 1.43% | 61,461,830 | |
| 1,654,355 | Institution | 1.13% | 48,406,427 | |
| 1,658,954 | Institution | 1.13% | 42,900,550 | |
| 1,553,434 | Institution | 1.06% | 39,861,116 | |
| 1,116,024 | Institution | 0.76% | 32,654,862 | |
| 976,664 | Institution | 0.67% | 28,577,189 | |
| 531,262 | Institution | 0.36% | 13,738,435 | |
| 422,090 | Institution | 0.29% | 10,915,247 | |
| 320,420 | Institution | 0.22% | 8,221,977 | |
| 264,617 | Institution | 0.18% | 7,742,693 |
FAQ
Who Owns Immunovant (IMVT)?
According to the latest TipRanks data, approximately 24.73% of the company's stock is held by institutional investors, 2.73% is held by insiders, and 48.08% is held by retail investors.
What percentage of Immunovant (IMVT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 24.73% of Immunovant (IMVT) stock is held by institutional investors.
What percentage of Immunovant (IMVT) stock is held by retail investors?
According to the latest TipRanks data, approximately 48.08% of Immunovant (IMVT) stock is held by retail investors.
Who owns the most shares of Immunovant (IMVT)?
Vanguard owns the most shares of Immunovant (IMVT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.